Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to $115000.0.

  • Caribou Biosciences' Capital Expenditures fell 8291.23% to $115000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 6847.42%. This contributed to the annual value of $4.9 million for FY2024, which is 5797.81% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Capital Expenditures is $115000.0, which was down 8291.23% from $418000.0 recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Capital Expenditures registered a high of $4.8 million during Q3 2023, and its lowest value of $95000.0 during Q1 2021.
  • Over the past 5 years, Caribou Biosciences' median Capital Expenditures value was $1.0 million (recorded in 2025), while the average stood at $1.4 million.
  • In the last 5 years, Caribou Biosciences' Capital Expenditures skyrocketed by 395000.0% in 2021 and then plummeted by 8583.75% in 2024.
  • Quarter analysis of 5 years shows Caribou Biosciences' Capital Expenditures stood at $685000.0 in 2021, then soared by 156.5% to $1.8 million in 2022, then rose by 29.6% to $2.3 million in 2023, then plummeted by 77.25% to $518000.0 in 2024, then plummeted by 77.8% to $115000.0 in 2025.
  • Its Capital Expenditures stands at $115000.0 for Q3 2025, versus $418000.0 for Q2 2025 and $1.0 million for Q1 2025.